Pathology of mesothelioma

Thoracic Surgery Clinics

Volumn 14, Issue 4 SPEC. ISS., 2004, Pages 447-460

  Corson, Joseph M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT MESOTHELIOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 4744368604     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2004.06.007     Document Type: Review

References (84)

1. V.I. Adams, K.K. Unni, J.R. Muhm, J.R. Jett, D.M. Ilstrup, and P.E. Bernatz Diffuse malignant mesothelioma of the pleura: diagnosis and survival in 92 cases Cancer 58 1986 1540 1551
2. C. Boutin, F. Rey, J. Gouvernet, J.R. Viallat, P.H. Astoul, and V. Ledoray Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients Cancer 72 2 1993 394 404
3. D.J. Sugarbaker, R.M. Flores, M.T. Jaklitsch, W.G. Richards, G.M. Strauss, and J.M. Corson Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 65
4. G. Maggi, C. Casadio, R. Giobbe, and E. Ruffini The management of malignant pleural mesothelioma [letter] Eur J Cardiothorac Surg 23 2003 255
5. T.B. Crotty, J.L. Myers, A.L.A. Katzenstein, H.D. Tazelaar, S.J. Swensen, and A. Churg Localized malignant mesothelioma: a clinicopathologic and flow cytometric study Am J Surg Pathol 18 4 1994 357 363
6. A. Churg, V. Roggli, T. Colby, P. Cagle, J. Corson, A.R. Gibbs and the US-Canadian Mesothelioma Reference Panel The separation of benign malignant mesothelial proliferations Am J Surg Pathol 24 9 2000 1183 1200
7. D.W. Henderson, K.B. Shilkin, and D. Whitaker Reactive mesothelial hyperplasia vs. mesothelioma, including mesothelioma in-situ Am J Clin Pathol 110 3 1998 397 404
8. H. Battifora, and W.T.E. McCaughey Diffuse malignant mesothelioma J. Rosai L.H. Sobin associate editor. Atlas of tumor pathology: tumors of the serosal membranes 1995 Armed Forces Institute of Pathology Washington, DC 17 84
9. P. Astoul, and C. Boutin Pleuroscopy in the management of malignant pleural mesothelioma B.W.S. Robinson A.P. Chahinian Mesothelioma 2002 Martin Dunitz London 127 142
10. M. Kannerstein, and J. Churg Desmoplastic diffuse malignant mesothelioma Progress in Surgical Pathology 2 1980 19 29
11. R. Cantin, M. Al-Jabi, and W.T.E. McCaughey Desmoplastic diffuse mesothelioma Am J Surg Pathol 6 3 1982 215 222
12. G.E. Wilson, P.S. Hasleton, and A.K. Chatterjee Desmoplastic malignant mesothelioma: a review of 17 cases J Clin Pathol 45 1992 295 298
13. M. Kannerstein, J. Churg, and W.T.E. McCaughey Histochemistry in the diagnosis of malignant mesothelioma Ann Clin Lab Sci 5 1973 207 211
14. J.M. Corson Pathology of malignant mesothelioma K. Antman J. Aisner Asbestos-related malignancy 1987 Grune & Stratton New York 179 199
15. M.J. Warhol, W.F. Hickey, and J.M. Corson Malignant mesothelioma: ultrastructural distinction from adenocarcinoma Am J Surg Pathol 6 4 1982 307 314
16. I. Dardick, M. Jabi, W.T.E. McCaughey, S. Deodhar, A.P.W. van Nostrand, and J.R. Srigley Diffuse epithelial mesothelioma: a review of the ultrastructural spectrum Ultrastruct Pathol 11 1987 503 533
17. M. Coleman, D.W. Henderson, and T.M. Mukherjee The ultrastructural pathology of malignant pleural mesothelioma P.P. Rosen R.E. Fechner Pathology annual 24(part 1) 1989 Appleton & Lange Norwalk (CT) 303 353
18. T.D. Oury, S.P. Hammar, and V.L. Roggli Ultrastructural features of diffuse malignant mesotheliomas Hum Pathol 29 1998 1382 1392
19. D. Henderson, K.B. Shilkin, D. Whitaker, H.D. Attwood, T.J. Constance, and R.H. Steele The pathology of malignant mesothelioma, including immunohistology and ultrastructure D. Henderson K.B. Shilkin S. Langlois D. Whitaker Malignant mesothelioma 1992 Hemisphere Publishing New York 69 139
20. V. Roggli, F. Sanfilippo, and J.D. Shelburne Mesothelioma V. Roggli S.D. Greenberg P.G. Pratt Pathology of asbestos-associated diseases 1992 Little, Brown Boston 109 164
21. nd edition 1994 Springer-Verlag New York 1463 1579
22. J.M. Corson, and A.A. Renshaw Pathology of mesothelioma J. Aisner R. Arriagada M.R. Green N. Martini M.C. Perry Comprehensive textbook of thoracic oncology 1996 Williams & Wilkins Baltimore 757 778
23. R.L. Attanoos, and A.R. Gibbs Pathology of malignant mesothelioma Histopathology 30 1997 403 418
24. M.R. Wick, and S.E. Mills Mesothelial proliferations: an increasing morphologic spectrum Am J Clin Pathol 113 2000 619 622
25. D. Daya, and W.T.E. McCaughey Well-differentiated papillary mesothelioma of the peritoneum: a clinicopathologic study of 22 cases Cancer 65 2 1990 292 296
26. J. Goldblum, and W.R. Hart Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: a clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors Am J Surg Pathol 19 10 1995 1124 1137
27. K.J. Butnor, T.A. Sporn, S.P. Hammar, and V.L. Roggli Well-differentiated papillary mesothelioma Am J Surg Pathol 25 10 2001 1304 1309
28. R.W. Brown, G.M. Clark, A.K. Tandon, and D.C. Allred Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma Hum Pathol 24 1993 347 354
29. N.G. Ordonez The value of antibodies 44â€"3A6, SM3, HMBE-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies Am J Surg Pathol 21 12 1997 1399 1408
30. J.R. Riera, C. Astengo-Osuna, J.A. Longmate, and H. Battifora The immunohistochemical diagnostic panel for epithelial mesothelioma: a re-evaluation after heat-induced epitope retrieval Am J Surg Pathol 21 12 1997 1409 1419
31. N.G. Ordonez Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma: review and update Am J Clin Pathol 112 1999 75 89
32. C.A. Moran, M.R. Wick, and S. Suster The role of immunohistochemistry in the diagnosis of malignant mesothelioma Semin Diagn Pathol 17 3 2000 178 183
33. P.M. Cury, D.N. Butcher, C. Fisher, B. Corrin, and A.G. Nicholson Value of mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura Mod Pathol 13 2 2000 107 112
34. N.G. Ordonez Value of thyroid transcription Factor-1, E-Cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and non-pulmonary adenocarcinoma Am J Surg Pathol 24 4 2000 598 606
35. R. Carella, G. Deleonardi, A. D'Errico, A. Salerno, E. Egarter-Vigl, and C. Seebacher Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis Am J Surg Pathol 25 1 2001 43 50
36. A. Segal, D. Whittaker, D. Henderson, and K. Shilkin Pathology of mesothelioma B.W.S. Robinson A.P. Chahinian Mesothelioma 2002 Martin Dunitz London 143 184
37. C. Doglioni, A.P. Dei Tos, L. Laurino, P. Iuzzolino, C. Chiarelli, and M.R. Celio Calretinin: a novel immunocytochemical marker for mesothelioma Am J Surg Pathol 20 9 1996 1037 1046
38. N.G. Ordonez Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma Mod Pathol 11 10 1998 929 933
39. R.L. Attanoos, R. Webb, S.D. Dojcinov, and A.R. Gibbs Malignant epithelioid mesothelioma: anti-mesothelial marker expression correlates with histological pattern Histopathology 39 2001 584 588
40. J.M. Corson Keratin protein immunohistochemistry in surgical pathology practice S. Sommers P.P. Rosen R.E. Fechner Pathology annual 24(part 2) 1986 Appleton-Century-Crofts Norwalk (CT) 47 81
41. K.M. Amin, L.A. Litzky, W.R. Smythe, A.M. Mooney, J.M. Morris, and D.J.Y. Mews Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma Am J Pathol 146 1995 344 356
42. S. Kumar-Singh, K. Segers, U. Rodeck, H. Backhovens, J. Bogers, and J. Weyler WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis J Pathol 181 1997 67 74
43. M.R. Foster, J.E. Johnson, S.J. Olson, and D.C. Allred Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas Arch Pathol Lab Med 125 2001 1316 1320
44. J.M. Corson, and G.P. Pinkus Mesothelioma: profile of keratin proteins and carcinoembryonic antigen. An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas Am J Pathol 108 1982 80 87
45. J.E. King, and P.S. Hasleton Immunohistochemistry and the diagnosis of malignant mesothelioma Histopathology 38 2001 471 476
46. N.G. Ordonez Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma Hum Pathol 29 1998 166 169
47. N.G. Ordonez Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma Am J Surg Pathol 22 10 1998 1215 1221
48. P.G. Chu, and L.M. Weiss Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases Mod Pathol 15 1 2002 6 10
49. N.P. Wang, S. Zee, R.J. Zarbo, C.E. Bacchi, and A.M. Gown Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas (formerly Applied Immunohistochemistry) Appl Immunohistochem Mol Morphol 3 1995 99 107
50. P. Chu, E. Wu, and L.M. Weiss Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases Mod Pathol 13 2000 962 972
51. T. Tot The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas Cancer 92 2001 2727 2732
52. B.T.Y. Lin, T. Colby, A.M. Gown, S.P. Hammar, R.B. Mertens, and A. Churg Malignant vascular tumors of the serous membranes mimicking mesothelioma: a report of 14 cases Am J Surg Pathol 20 12 1996 1431 1439
53. B.R. DeYoung, H.F. Frierson, M.N. Ly, D. Smith, and P.E. Swanson CD31 immunoreactivity in carcinomas and mesotheliomas Am J Clin Pathol 110 1998 374 377
54. P.J. Zhang, V.A. Livolsi, and J.J. Brooks Malignant epithelioid vascular tumors of the pleura: report of a series and literature review Hum Pathol 31 2000 29 34
55. C.A. Moran, W.D. Travis, M. Rosado-de-Christenson, M.N. Koss, and J. Rosai Thymomas presenting as pleural tumors: report of eight cases Am J Surg Pathol 16 2 1992 138 144
56. R.L. Attanoos, F. Galateau-Salle, A.R. Gibbs, S. Muller, F. Ghandour, and S.D. Dojcinov Primary thymic epithelial tumors of the pleura mimicking malignant mesothelioma Histopathology 41 2002 42 49
57. MIC2) immunoreactivity in the diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders: a study of paraffin sections using monoclonal antibody 013 (formerly Applied Immunohistochemistry) Appl Immunohistochem Mol Morphol 4 1 1996 34 42
58. D.M. Dorfman, A. Shahsafaei, and J.K.C. Chan Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity Am J Surg Pathol 21 8 1997 936 940
59. D.W. Henderson, H.D. Attwood, T.J. Constance, K.B. Shilkin, and R.H. Steele Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma Ultrastruct Pathol 12 1988 367 384
60. H.S. Khalidi, J.L. Medeiros, and H. Battifora Lymphohistiocytoid mesothelioma: an often misdiagnosed variant of sarcomatoid malignant mesothelioma Am J Clin Pathol 113 2000 649 654
61. F. Galateau-Salle, J.M. Vignaud, I. Burke, G. Launoy, I. Abdalsamad, and E. Brambilla Lymphohistiocytoid mesothelioma: a series of 21 cases [abstract] Mod Pathol 16 2003 307A
62. F.G. Mayall, H. Goddard, and A.R. Gibbs Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon Histopathology 21 1992 453 457
63. J. Hurlimann Desmin and neural marker expression in mesothelial cells and mesotheliomas Hum Pathol 25 1994 753 757
64. I.T.M. Kung, V. Thallas, E.J. Spencer, and S.M. Wilson Expression of muscle actins in diffuse mesotheliomas Hum Pathol 26 1995 565 570
65. E. Gaertner, E.H. Zeren, M.V. Fleming, T.V. Colby, and W.D. Travis Biphasic synovial sarcomas arising in the pleural cavity: a clinicopathologic study of five cases Am J Surg Pathol 20 1 1996 36 45
66. S.B. Ng, Q. Ahmed, S.L. Tien, C. Sivaswaren, and L.C. Lau Primary pleural synovial sarcoma: a case report and review of the literature Arch Pathol Lab Med 127 2003 85 90
67. L.R. Essary, S.O. Vargas, and C.D.M. Fletcher Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset Cancer 94 2002 459 469
68. M. Chilosi, F. Facchetti, A.P. Dei Tos, M. Lestani, M.L. Morassi, and G. Martignoni bcl-2 Expression in pleural and extrapleural solitary fibrous tumours J Pathol 181 1997 362 367
69. A.G. Nicholson, P. Goldstraw, and C. Fisher Synovial sarcoma of the pleura and its differentiation from other primary pleural tumours: a clinicopathological and immunohistochemical review of three cases Histopathology 33 1998 508 513
70. S. Suster, C. Fisher, and C.A. Moran Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract Am J Surg Pathol 22 1998 863 872
71. M.C. Aubry, J.A. Bridge, R. Wickert, and H.D. Tazelaar Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript Am J Surg Pathol 25 6 2001 776 781
72. A.S. Colwell, J. D'Cunha, S.O. Vargas, B. Parker, P.D. Cin, and M.A. Maddaus Synovial sarcoma of the pleura: a clinical and pathologic study of three cases J Thorac Cardiovasc Surg 124 2002 828 832
73. M. Carbone, P. Rizzo, A. Powers, M. Bocchetta, R. Fresco, and T. Krausz Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications Anticancer Res 22 2002 3443 3448
74. C. Fisher, D.R.H. deBruijn, and A.G. van Kessel Synovial sarcoma C.D.M. Fletcher K.K. Unni F. Mertens World Health Organization of Tumours. Pathology and genetics of tumours of soft tissue and bone 2002 IARC Lyon 200 204
75. M. Van de Rijn, F.G. Barr, M.H. Collins, Q.B. Xiong, and C. Fisher Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma Am J Clin Pathol 112 1999 43 49
76. D.M. England, L. Hochholzer, and M.J. McCarthy Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases Am J Surg Pathol 13 8 1989 640 658
77. N.G. Ordonez Localized (solitary) fibrous tumor of the pleura Adv Anat Pathol 7 6 2000 327 340
78. L. Guillou, J.A. Fletcher, C.D.M. Fletcher, and N. Mandahl Extrapleural solitary fibrous tumor C.D.M. Fletcher K.K. Unni F. Mertens Pathology and genetics of tumors of soft tissue and bone 2002 IARC Lyon 86 88
79. A.A. Renshaw, G.S. Pinkus, and J.M. Corson CD34 and AE1/AE3. Diagnostic discriminants in the distinction of solitary fibrous tumor of the pleura from sarcomatoid mesothelioma (formerly Applied Immunohistochemistry) Appl Immunohistochem Mol Morphol 2 1994 94 102
80. M. van de Rijn, C.M. Lombard, and R.V. Rouse Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung Am J Surg Pathol 18 8 1994 814 820
81. W.H. Westra, W.L. Gerald, and J. Rosai Solitary fibrous tumor: consistent CD34 immunoreactivity and occurrence in the orbit Am J Surg Pathol 18 10 1994 992 998
82. W.E. Mangano, P.T. Cagle, A. Churg, R.T. Vollmer, and V.L. Roggli The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining Am J Clin Pathol 110 1998 191 199
83. T.V. Colby The diagnosis of desmoplastic malignant mesothelioma Am J Clin Pathol 110 1998 135 136
84. rd edition. New York: Springer-Verlag; 1999. p. 51-4